日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

替诺福韦艾拉酚胺 (TAF) 和富马酸替诺福韦二吡呋酯 (TDF) 序贯 TAF 治疗 5 年后，对东亚裔慢性乙型肝炎患者的疗效和安全性进行评估

期刊:Alimentary Pharmacology & Therapeutics
影响因子:6.7
doi:10.1111/apt.70327
Wong, Grace Lai-Hung; Gane, Edward; Pan, Calvin Q; Fung, Scott; Ma, Mang M; Izumi, Namiki; Shalimar; Lim, Seng Gee; Chuang, Wan-Long; Mehta, Rajiv; Lim, Young-Suk; Yee, Leland J; Flaherty, John F; Abramov, Frida; Wang, Hongyuan; Buti, Maria
肝炎
发表日期：2026
文献求助 收藏

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta

布列韦肽单药治疗或联合聚乙二醇干扰素α-2a治疗慢性丁型肝炎的II期随机研究

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70008
Lampertico, Pietro; Bogomolov, Pavel O; Chulanov, Vladimir; Stepanova, Tatiana; Morozov, Viacheslav; Allweiss, Lena; Dandri, Maura; Burhenne, Jürgen; Blank, Antje; Ciesek, Sandra; Elsner, Carina; Dittmer, Ulf; An, Qi; Manuilov, Dmitry; Da, Ben L; Flaherty, John F; Urban, Stephan; Wedemeyer, Heiner
肝炎
发表日期：2025
文献求助 收藏

Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48

布来韦肽单药治疗慢性丁型肝炎安全且耐受性良好：布来韦肽临床试验第 48 周的综合安全性分析

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.16174
Asselah, Tarik; Lampertico, Pietro; Aleman, Soo; Bourlière, Marc; Streinu-Cercel, Adrian; Bogomolov, Pavel; Morozov, Viacheslav; Stepanova, Tatiana; Lazar, Stefan; Manuilov, Dmitry; Mercier, Renee-Claude; Tseng, Steve; Ye, Lei; Flaherty, John F; Osinusi, Anu; Da, Ben L; Chee, Grace M; Lau, Audrey H; Brunetto, Maurizia R; Wedemeyer, Heiner
肝炎
发表日期：2025
文献求助 收藏

Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral therapy for hepatitis B virus can decrease kidney disease risk

慢性乙型肝炎病毒感染会增加肾脏疾病的风险，而乙型肝炎病毒抗病毒治疗可以降低肾脏疾病的风险。

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-025-03991-x
Ito, Kaori L; Zhang, Yuqing; Li, Biao; King, Andrew; Yee, Leland J; Frenette, Catherine; Abramov, Frida; Flaherty, John F; Malkov, Vladislav A
炎症/感染
肝炎
微生物学
发表日期：2025
文献求助 收藏

Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

长期使用替诺福韦艾拉酚胺治疗慢性乙型肝炎可获得较高的病毒抑制率，且肾脏和骨骼安全性良好。

期刊:American Journal of Gastroenterology
影响因子:7.6
doi:10.14309/ajg.0000000000002468
Chan, Henry L Y; Buti, Maria; Lim, Young-Suk; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia; Chuang, Wan-Long; Janssen, Harry L A; Fung, Scott; Izumi, Namiki; Abdurakhmanov, Dzhamal; Jabłkowski, Maciej; Celen, Mustafa K; Ma, Xiaoli; Caruntu, Florin; Flaherty, John F; Abramov, Frida; Wang, Hongyuan; Camus, Gregory; Osinusi, Anu; Pan, Calvin Q; Shalimar; Seto, Wai-Kay; Gane, Edward
微生物学
肝炎
发表日期：2024
文献求助 收藏

Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials

替诺福韦艾拉酚胺治疗慢性乙型肝炎病毒感染的八年疗效和安全性：两项随机3期试验的最终结果

期刊:Alimentary Pharmacology & Therapeutics
影响因子:6.7
doi:10.1111/apt.18278
Buti, Maria; Lim, Young-Suk; Chan, Henry Lik Yuen; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia R; Chuang, Wan-Long; Janssen, Harry L A; Fung, Scott K; Izumi, Namiki; Jablkowski, Maciej S; Abdurakhmanov, Dzhamal; Abramov, Frida; Wang, Hongyuan; Botros, Irina; Yee, Leland J; Mateo, Roberto; Flaherty, John F; Osinusi, Anu; Pan, Calvin Q; Shalimar, X; Seto, Wai-Kay; Gane, Edward J
炎症/感染
肝炎
微生物学
发表日期：2024
文献求助 收藏

Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients

替诺福韦艾拉酚胺治疗五年，在中国慢性乙型肝炎患者中实现了较高的病毒抑制率、丙氨酸氨基转移酶正常化率以及良好的骨骼和肾脏安全性。

期刊:Journal of Clinical and Translational Hepatology
影响因子:4.2
doi:10.14218/JCTH.2023.00417
Hou, Jinlin; Ning, Qin; Duan, Zhongping; Chen, Yu; Xie, Qing; Zhang, Lunli; Wu, Shanming; Tang, Hong; Li, Jun; Lin, Feng; Yang, Yongfeng; Gong, Guozhong; Luo, Yanwen; Xie, Shelley; Wang, Hongyuan; Mateo, Roberto; Yazdi, Tahmineh; Abramov, Frida; Yee, Leland J; Flaherty, John; Chen, Chengwei; Huang, Yan; Zhang, Mingxiang; Jia, Jidong
微生物学
肝炎
发表日期：2024
文献求助 收藏

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B

替诺福韦艾拉酚胺和富马酸替诺福韦酯可降低慢性乙型肝炎患者肝细胞癌的发生率

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2023.100847
Lim, Young-Suk; Chan, Henry L Y; Ahn, Sang Hoon; Seto, Wai Kay; Ning, Qin; Agarwal, Kosh; Janssen, Harry L A; Pan, Calvin Q; Chuang, Wan Long; Izumi, Namiki; Fung, Scott; Shalimar; Brunetto, Maurizia; Hui, Aric Josun; Chang, Ting-Tsung; Lim, Seng Gee; Abramov, Frida; Flaherty, John F; Wang, Hongyuan; Yee, Leland J; Kao, Jia-Horng; Gane, Edward; Hou, Jinlin; Buti, Maria
细胞生物学
肿瘤
肝炎
肿瘤免疫
发表日期：2023
文献求助 收藏

Nutritional needs, resources, and barriers among unhoused adults cared for by a street medicine organization in Chicago, Illinois: a cross-sectional study

伊利诺伊州芝加哥市一家街头医疗组织照料的无家可归成年人的营养需求、资源和障碍：一项横断面研究

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-023-16790-6
Adams, Elizabeth J; Lu, Michelle; Duan, Richard; Chao, Alyssa K; Kessler, Helen C; Miller, Charles D; Richter, Adam G; Latyshev, Daniel G; Dastoor, Jehannaz D; Eckburg, Adam J; Kadambi, Namrata S; Suresh, Nila R; Bales, Cayla E; Green, Hannah M; Camp, Daniel M; Jara, Rolando; Flaherty, John P
发表日期：2023
文献求助 收藏

Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B

早期治疗慢性乙型肝炎获益的证据

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v15040997
Lim, Young-Suk; Kim, W Ray; Dieterich, Douglas; Kao, Jia-Horng; Flaherty, John F; Yee, Leland J; Roberts, Lewis R; Razavi, Homie; Kennedy, Patrick T F
肝炎
发表日期：2023
文献求助 收藏